nad has been researched along with 3-nitropropionic acid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fink, F; Ludolph, AC; Oexle, K; Riepe, MW; Schmalzigaug, K | 1 |
| Dirnagl, U; Esclaire, F; Hugon, J; Kasischke, K; Kempski, O; Ludolph, AC; Nakase, H; Riepe, MW; Schreiber, S | 1 |
| Huber, R; Kasischke, K; Li, H; Riepe, MW; Timmler, M | 1 |
| Büchner, M; Huber, R; Li, H; Riepe, MW; Schlieter, M; Speerfeld, AD; Sperfeld, AD | 1 |
| Büchner, M; Huber, R; Riepe, MW; Staufenbiel, M; Sturchler-Pierrat, C | 1 |
| Huber, R; Lange-Asschenfeldt, C; Lohmann, P; Riepe, MW | 1 |
| Cai, AL; Sheline, CT; Shi, C; Zhang, W; Zhu, J | 1 |
| Calvo-Silva, FJ; Fernández-Valverde, F; García-Morales, J; Orozco-Ibarra, M; Serrano-García, N | 1 |
8 other study(ies) available for nad and 3-nitropropionic acid
| Article | Year |
|---|---|
NADH in the pyramidal cell layer of hippocampal regions CA1 and CA3 upon selective inhibition and uncoupling of oxidative phosphorylation.
Topics: 2,4-Dinitrophenol; Amobarbital; Animals; Fluorometry; Hippocampus; In Vitro Techniques; Male; NAD; Nitro Compounds; Oxidative Phosphorylation; Propionates; Pyramidal Cells; Rats; Rats, Wistar; Sodium Cyanide; Uncoupling Agents | 1996 |
Increased hypoxic tolerance by chemical inhibition of oxidative phosphorylation: "chemical preconditioning".
Topics: Adenosine Triphosphate; Animals; Brain Ischemia; Cell Hypoxia; Enzyme Inhibitors; Free Radicals; Glyburide; Hippocampus; Hypoxia, Brain; Male; NAD; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nitro Compounds; Oxidative Phosphorylation; Potassium Channels; Propionates; Rats; Rats, Wistar; Reactive Oxygen Species; Succinate Dehydrogenase | 1997 |
Primary hypoxic tolerance and chemical preconditioning during estrus cycle in mice.
Topics: Action Potentials; Adaptation, Physiological; Animals; Aspirin; Dose-Response Relationship, Drug; Estrus; Female; Hippocampus; Hypoxia; In Vitro Techniques; Injections, Intraperitoneal; Male; Mice; Mice, Inbred Strains; NAD; Nitro Compounds; Propionates; Sex Characteristics | 1999 |
Protein binding of NADH on chemical preconditioning.
Topics: Animals; Cell Hypoxia; Enzyme Inhibitors; Hippocampus; Male; Mice; NAD; Nitro Compounds; Oxidative Phosphorylation; Propionates; Protein Binding; Spectrometry, Fluorescence; Succinate Dehydrogenase; Tissue Distribution | 2000 |
Impaired hypoxic tolerance and altered protein binding of NADH in presymptomatic APP23 transgenic mice.
Topics: Action Potentials; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Energy Metabolism; Female; Hippocampus; Hypoxia, Brain; Ischemic Preconditioning; Male; Mice; Mice, Transgenic; NAD; Neurons; Nitro Compounds; Propionates; Protein Binding; Recovery of Function; Spectrum Analysis | 2002 |
The stamp of ancestry: roots of behavioral and neuronal impairment in adulthood.
Topics: Age Factors; Animals; Animals, Newborn; Female; Hypoxia; Learning; Long-Term Potentiation; Male; Mice; NAD; Neurons; Nitro Compounds; Pregnancy; Prenatal Exposure Delayed Effects; Propionates; Spectrometry, Fluorescence | 2006 |
Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Cation Transport Proteins; Cell Death; Cells, Cultured; Cerebral Cortex; Dihydroxyacetone Phosphate; Disease Models, Animal; Drug Interactions; Embryo, Mammalian; Fructose-Bisphosphatase; Humans; Huntington Disease; Male; Matrix Metalloproteinase 16; Membrane Proteins; Membrane Transport Proteins; Mental Disorders; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Mice, Transgenic; NAD; Neurons; Niacinamide; Nitro Compounds; Oxidopamine; Parkinson Disease; Propionates; Pyruvic Acid; Rats; Rats, Long-Evans; Tyrosine 3-Monooxygenase; Zinc | 2013 |
Striatal mitochondria response to 3-nitropropionic acid and fish oil treatment.
Topics: Animals; Antioxidants; Corpus Striatum; Cytochrome-c Peroxidase; Disease Models, Animal; Dose-Response Relationship, Drug; Electron Transport Complex II; Electron Transport Complex IV; Fish Oils; Huntington Disease; In Situ Nick-End Labeling; Lipid Peroxidation; Male; Mitochondria; NAD; Neuroprotective Agents; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar | 2018 |